IP Library Granted Patent US 9,176,031
Granted Patent B2
US 9,176,031 · App. 13/774,437 · Granted Nov 3, 2015

Labeling and sample preparation for sequencing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,176,031
App. No.
13/774,437
Granted
Nov 3, 2015
Kind
B2
Abstract

The invention provides methods for sequencing and sample preparation for sequencing and amplification.

Claims (28)

1. A method for preparing nucleic acid for analysis, the method comprising the steps of:

fragmenting nucleic acid molecules from a sample into long fragments comprising a length in a range of 5 kilobases-100 kilobases and short fragments comprising a length in a range of 100 bases-1000 bases;

attaching an adaptor to each of 3′ and 5′ ends of the short fragments;

hybridizing a plurality of the short fragments from the sample to individual long fragments from the sample to form a plurality of fragment complexes;

compartmentalizing the fragment complexes in droplets with a primer pair species complementary to adaptors attached to the short fragments, wherein each droplet comprises one fragment complex and the primer pair species comprises a barcode; and

amplifying the short fragments from the fragment complex in each droplet using the primer pair species.

2. The method according to claim 1 , wherein removing comprises conducting a gel purification assay that separates the hybridized fragments from the unhybridized short fragments.

3. The method according to claim 1 , wherein prior to the hybridizing step, the method further comprises attaching a first member of a binding pair to the long fragments.

4. The method according to claim 3 , further comprising the step of removing unhybridized short fragments that comprises exposing the fragment complexes and the unhybridized short fragments to a solid support comprising a second member of the binding pair such that the fragment complexes bind to the solid support via the binding pair and are separated from the unhybridized short fragments that do not bind the support.

5. The method according to claim 4 , wherein the binding pair is selected from the group consisting of: biotin/streptavidin; carbohydrate/lectin; and antibody/antigen.

6. The method according to claim 1 , wherein compartmentalizing comprises:

encapsulating the primer pair species into the droplets; and

introducing the fragment complexes to the droplets.

7. The method according to claim 1 , wherein the droplets comprise an aqueous fluid surrounded by an immiscible fluid.

8. The method according to claim 7 , wherein compartmentalizing comprises partitioning the aqueous fluid as it is flowing through a channel with the immiscible fluid.

9. The method according to claim 8 , wherein the immiscible fluid is oil.

10. The method according to claim 9 , wherein the oil is a fluorinated oil.

11. The method according to claim 9 , wherein the oil comprises a surfactant.

12. The method according to claim 11 , wherein the surfactant is a fluorosurfactant.

13. The method according to claim 1 , wherein compartmentalizing comprises merging the droplet that comprises the fragment complex with a droplet comprising the primer pair species.

14. The method according to claim 13 , wherein merging occurs in the presence of an electric field.

15. The method according to claim 1 , wherein compartmentalizing comprises merging a portion of a fluid stream comprising the fragment complex with a droplet comprising the barcoded primers.

16. The method according to claim 15 , wherein merging occurs in the presence of an electric field.

17. The method according to claim 1 , wherein amplifying is by polymerase chain reaction.

18. The method according to claim 1 , further comprising sequencing the amplified short fragments and aligning obtained sequence reads.

19. The method according to claim 1 , wherein the primer pair species further comprises a universal priming site.

20. The method according to claim 19 , wherein the universal priming site is used for sequencing.

21. The method according to claim 1 , wherein the barcode identifies the droplet.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2019
From: RAINDANCE TECHNOLOGIES, INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 049109/0498 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CRG ISSUER 2015-1
To: RAINDANCE TECHNOLOGIES, INC.
Reel/Frame 041290/0585 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2014
From: WATSON, ANDREW, MR.
To: RAINDANCE TECHNOLOGIES, INC.
Reel/Frame 033484/0671 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Sep 17, 2013
From: RAINDANCE TECHNOLOGIES, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031267/0376 →